isabelobrien, Author at European Medical Journal - Page 25 of 68

How HCPs consumed medical content in 2024

This infographic explores how healthcare professionals engaged with medical content in 2024, highlighting their HCP content preferences and more.

FDA fast-tracks Boehringer's NSCLC drug review

The FDA has granted priority review to zongertinib for non-small cell lung cancer (NSCLC).

Donal Brennan

Onc Now: Episode 11: The Obesity Cancer Connection

Donal Brennan shares insights on ovarian cancer surgery, obesity-related carcinogenesis, and innovations in patient care.

Data

ABPI urges NHS to improve data access for pharma research

A new cross-industry report is calling for the UK’s NHS to design its health data infrastructure to meet the needs of pharma researchers.

Jade Williams and Isabel O'Brien, EMJ GOLD

Does interactivity boost memory, recall and retention?

Explore the science behind memory, recall and retention, and uncover why interactive content could be the future in this podcast.

FDA approves first at-home coeliac genetic test

A new at-home genetic test that assesses the risk of developing coeliac disease has received approval from US regulators.

Kennedy secures US health role despite backlash

Robert F. Kennedy Jr has been confirmed as the US Secretary of Health and Human Services following a 52-48 Senate vote.

Britain

ABPI reveals data on UK’s life sciences competitive edge

A new survey from the ABPI has revealed a surge in apprenticeships, placements and global research collaborations in the UK pharma space.

5 minutes with... Jaime Manzanera, Eisai

Jaime Manzanera, EMEA Brand Director, Oncology, Eisai, shares his perspective on maximising ROI in pharmaceutical marketing and more.

Frederik-Schjesvold

Hema Now: Episode 10: Shaping the Future of Myeloma

Fredrik Schjesvold, Head of the Oslo Myeloma Center, Oslo University Hospital, and Head of the Norwegian myeloma association joins the show.